Cornelis Adriaan De Kruif

This inventor holds 54 USPTO granted patents and 25 published patent applications, plus 3 CIPO patents and 26 EPO patents, primarily in Biopharmaceutical Antibodies. Top assignees: Crucell Holland B.v., Merus N.v., Merus B.v.. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cornelis Adriaan De Kruif. Retrieved from https://idiyas.com/inventor/cornelis-adriaan-de-kruif

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 54 (Patent Applications = 25)

% Patents Active = 70.4

CIPO Patents = 3

EPO Patents = 26 (Patent Applications = 23)

Average Co-Inventor Count = 3.2

ph-index = 18

Forward Citations = 782(Granted Patents)

Location History:

El De Bilt, NL (2006 - 2013)
De Bilt, NL (2007 - 2023)
Utrecht, NL (2016 - 2024)

Company Filing History:

Janssen Vaccines & Prevention B.v.

patents

where one patent can have more than one assignee

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

Binding Proteins

Immunoglobulin Libraries

Cancer Treatment

Neutralizing Antibodies

ErbB-2

ErbB-3

EGFR

cMET

PD-1

TIM-3

Influenza Virus

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12723095 - METHODS OF TREATING CANCER USING BINDING MOLECULES THAT BIND CD137 AND PD-L1 (2026-09-01),

2. 12668638 - ANTIBODIES THAT BIND EGFR AND CMET (2026-06-30),

3. 12577327 - MIXED BINDING DOMAINS (2026-03-17),

4. 12577306 - BISPECIFIC ANTI PD1-ANTI TIM3 ANTIBODIES (2026-03-17),

5. 12570747 - TGF-BETA-RII BINDING PROTEINS (2026-03-10),

6. 12139548 - Antibody that binds ErbB-2 and ErbB-3 (2024-11-12),

7. 12123043 - Methods and means for the production of Ig-like molecules (2024-10-22),

8. 11952424 - Multivalent antibody (2024-04-09),

9. 11926859 - Methods and means for the production of Ig-like molecules (2024-03-12),

10. 11785924 - Antibody producing non-human animals (2023-10-17),

11. 11773170 - Antibodies that bind EGFR and cMET (2023-10-03),

12. 11753470 - Bispecific anti PD1-anti TIM3 antibodies (2023-09-12),

13. 11732043 - Antibodies that modulate a biological activity expressed by a cell (2023-08-22),

14. 11685786 - Binding molecules that bind CD137 and PD-L1 (2023-06-27),

15. 11667714 - Binding molecules that modulate a biological activity expressed by a cell (2023-06-06),

Title: Cornelis Adriaan De Kruif - The Innovative Mind from De Bilt

Introduction: Cornelis Adriaan De Kruif, a distinguished inventor hailing from De Bilt, NL, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: De Kruif's latest patents focus on advancements in renewable energy technologies, particularly in the development of solar-powered devices for sustainable living.

Career Highlights: Throughout his illustrious career, De Kruif has been instrumental in revolutionizing the way we harness and utilize energy. His innovative solutions have earned him recognition as a pioneer in the renewable energy sector.

Collaborations: De Kruif has collaborated with leading research institutions and universities to further his research and bring his inventions to life. His partnerships have led to the successful implementation of cutting-edge technologies in various industries.

Conclusion: Cornelis Adriaan De Kruif's relentless pursuit of innovation and commitment to sustainability have solidified his position as a visionary inventor shaping the future of technology.

Profile summary based on public USPTO records.